United States· US:72189-549_23080f85-3974-7803-e063-6394a90aa11d
Olmesartan Medoxomil
A olmesartan medoxomil product containing olmesartan medoxomil, registered in United States by Direct_Rx. The same ATC class is registered in 15 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Olmesartan medoxomil is registered in 15 of 19 countries.
Countries holding a registration under ATC C09CA08 (olmesartan medoxomil), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 10 of them publish a price we can compare per daily dose
Olmesartan medoxomil · ATC C09CA08
15 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Switzerlandprice
- United Statesprice
Price per daily dose
What a daily dose of olmesartan medoxomil costs, country by country.
Normalised to the WHO defined daily dose (20 mg), the median price runs from $0.33 in Italy to $0.86 in Switzerland — a ×2.6 gap.
- 3 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Olmesartan medoxomil · price per daily dose (20 mg)
USD · FX 28 Sept 2026
- CH Switzerland$0.86
- ES Spain$0.41
- IT Italy$0.33
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- OLMESARTAN MEDOXOMIL
- Manufacturer
- Direct_Rx
- Country
- United States (US)
- ATC code
- C09CA08
- ATC class
- Olmesartan medoxomil
- Defined daily dose
- 20 mg, O
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 4
- ndc11721895493030 TABLET, FILM COATED in 1 BOTTLE (72189-549-30)
- ndc11721895499090 TABLET, FILM COATED in 1 BOTTLE (72189-549-90)
- ndc1172189-549-30
- ndc1172189-549-90
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
216 interactions on record for olmesartan medoxomil.
Graded by severity as the source publishes them — 7 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Olmesartan medoxomil · interactions on record
216 records
- 7 severe
- 128 moderate
Most severe, free to view
- Potassium chlorideA12BA01severe
- Potassium citrateA12BA02severe
- Potassium gluconateA12BA05severe
- Potassium chlorideB05XA01severe
81 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Olmesartan medoxomil in 9 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumBelsar 40 mgMenarini International Operations Luxembourg
- CzechiaSARTENMenarini International Operations Luxembourg S.A., Luxembourg
- ItalyCARDOLS.F. GROUP S.R.L.
- FinlandBenetorMenarini International Operations Luxembourg S.A.
- IrelandOlmesartan Krka 40 mg film-coated tabletsKRKA, d.d., Novo mesto
- FranceALTEIS 40 mg, comprimé pelliculéMENARINI INTERNATIONAL OPERATIONS LUXEMBOURG
- NorwayOlmesartan Medoxomil AccordAccord Healthcare B.V.
- CanadaACH-OLMESARTANACCORD HEALTHCARE INC
Authorised across Europe · EMA
The same active substance is authorised in 28 EEA countries. Names it is sold under:
- Austria · Mencord, Olmeblo
- Belgium · Belsar, Olmesartan Ab
- Bulgaria · Tansidor, Амлосарт
- Cyprus · Olmesartan Medoxomil Jubilant, Olmesartan Tad
- Czechia · Sarten, Zeota
- Germany · Olmecor, Olmes
- Denmark · Olmesartan Medoxomil Krka
- Estonia · Mesar, Olimestra
- Spain · Atolme, Ixia
- Finland · Olmesartan Medoxomil Krka, Olmesartan Medoxomil Stada
- France · Alteis, Olmetec
- United Kingdom (Northern Ireland) · Olmesartan, Olmesartan Glenmark Pharmaceuticals Europe
- Greece · Ipertas, Olmesartan Sandoz
- Croatia · Olimestra, Olmesartan Genericon
- Hungary · Laresin
- Ireland · Olmesartan Krka, Olmesartan Medoxomil Accord Healthcare
- Italy · Cardol, Idalman
- Lithuania · Mesar, Olimestra
- Luxembourg · Belsar, Olmesartan Eg
- Latvia · Mesar, Olimestra
- Malta · Olmesartan Aurobindo Pharma (Malta), Olmesartan Vocate
- Netherlands · Olmesartan Medoxomil Accord, Olmesartan Medoxomil Aurobindo
- Norway · Olmesartan Medoxomil Accord, Olmesartan Medoxomil Krka
- Poland · Olimestra, Olmesartan Lek-Am
- Portugal · Atolme, Condronac
- Romania · Olmetec, Santini
- Slovenia · Olimestra, Tensiol
- Slovakia · Tenzar
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ba73e007-ecb2-47b4-8af9-c1d001af3872 GET /v1/drugs/ba73e007-ecb2-47b4-8af9-c1d001af3872?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "40",
"substance": "OLMESARTAN MEDOXOMIL",
"productndc": "72189-549",
"dosage_form": "TABLET, FILM COATED",
"dea_schedule": null,
"strength_unit": "mg/1",
"application_number": "ANDA204798",
"marketing_category": "ANDA"
}See everything about olmesartan medoxomil.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.